Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
31.82B | 29.51B | 28.68B | 29.18B | 23.11B | 26.16B | Gross Profit |
8.60B | 7.60B | 7.04B | 7.13B | 5.52B | 6.77B | EBIT |
1.73B | 1.38B | 1.13B | 1.68B | 616.61M | 1.21B | EBITDA |
3.09B | 2.83B | 4.18B | 3.62B | 2.17B | 2.14B | Net Income Common Stockholders |
968.72M | 785.63M | 1.37B | 1.32B | 651.31M | 624.83M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.39B | 6.21B | 5.09B | 6.11B | 5.36B | 4.12B | Total Assets |
44.67B | 43.25B | 40.80B | 40.53B | 36.07B | 35.74B | Total Debt |
7.46B | 6.76B | 6.08B | 5.88B | 6.13B | 6.71B | Net Debt |
1.07B | 552.76M | 993.01M | 35.88M | 770.08M | 2.58B | Total Liabilities |
18.14B | 17.42B | 16.40B | 18.93B | 17.16B | 17.54B | Stockholders Equity |
22.86B | 22.28B | 21.45B | 19.49B | 17.33B | 16.71B |
Cash Flow | Free Cash Flow | ||||
202.31M | 1.34B | -1.44B | 651.23M | 1.92B | 1.15B | Operating Cash Flow |
2.21B | 3.23B | 162.21M | 1.63B | 3.02B | 2.45B | Investing Cash Flow |
-1.78B | -1.53B | -1.10B | -366.57M | -629.78M | -1.63B | Financing Cash Flow |
-275.73M | -535.51M | -399.08M | -732.64M | -998.76M | -597.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.21B | 9.59 | 2.23% | 2.63% | 267.72% | ||
79 Outperform | ¥13.18B | 9.41 | 2.71% | 20.91% | 18.64% | ||
75 Outperform | ¥10.83B | 8.10 | 5.68% | 13.50% | 63.21% | ||
71 Outperform | ¥11.09B | 9.04 | 3.25% | 0.94% | 3.05% | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
54 Neutral | ¥5.28B | ― | 1.82% | 10.20% | -142.31% |